CapsoVision Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	13.09	11.76	9.75
Revenue Growth (YoY)	34.20%	20.54%	-
Cost of Revenue	6.14	5.38	4.26
Gross Profit	6.95	6.38	5.49
Selling, General & Admin	13.93	11.17	7.51
Research & Development	15.71	15.12	9.33
Operating Expenses	29.64	26.29	16.84
Operating Income	-22.69	-19.92	-11.35
Interest & Investment Income	0.18	0.03	0.05
Other Non Operating Income (Expenses)	-0.04	0	0
Pretax Income	-22.55	-19.89	-11.29
Income Tax Expense	0.01	0.01	0.01
Net Income	-22.56	-19.9	-11.31
Net Income to Common	-22.56	-19.9	-11.31
Shares Outstanding (Basic)	13	2	2
Shares Outstanding (Diluted)	13	2	2
Shares Change (YoY)	650.30%	14.74%	-
EPS (Basic)	-1.69	-9.76	-6.36
EPS (Diluted)	-1.69	-9.76	-6.36
Free Cash Flow	-20.66	-20.24	-11.56
Free Cash Flow Per Share	-1.55	-9.93	-6.50
Gross Margin	53.13%	54.24%	56.30%
Operating Margin	-173.33%	-169.42%	-116.34%
Profit Margin	-172.37%	-169.26%	-115.91%
Free Cash Flow Margin	-157.85%	-172.20%	-118.49%
EBITDA	-22.47	-19.71	-11.21
EBITDA Margin	-171.71%	-167.67%	-114.90%
D&A For EBITDA	0.21	0.21	0.14
EBIT	-22.69	-19.92	-11.35
EBIT Margin	-173.33%	-169.42%	-116.34%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q